PIN81 Cost-Effectiveness Analysis of Peg-Interferon Alpha-2A Plus Ribavirin Versus Conventional Interferon Alpha-2A Plus Ribavirin for the Treatment of Chronic Hepatitis C in China
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.267
https://www.valueinhealthjournal.com/article/S1098-3015(11)01829-8/fulltext
Title :
PIN81 Cost-Effectiveness Analysis of Peg-Interferon Alpha-2A Plus Ribavirin Versus Conventional Interferon Alpha-2A Plus Ribavirin for the Treatment of Chronic Hepatitis C in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01829-8&doi=10.1016/j.jval.2011.08.267
First page :
A280
Section Title :
Infection
Open access? :
No
Section Order :
246